Amylyx Pharmaceuticals Inc (AMLX)

Amylyx Pharmaceuticals Inc (AMLX) 財務データ

損益計算書

四半期ごと

*すべての数値は百万単位です

期間終了日	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	18.26% 88.64	108.45	102.69	98.22	71.43
Cost Of Revenue	36.49% 5.945	9.36	5.218	5.58	5.283
Gross Profit	16.54% 82.70	99.09	97.47	92.64	66.14
Operating Expenses	110.83% 204.83	97.16	78.75	72.44	68.20
Benefits Costs and Expenses	103.19% 207.19	101.97	80.28	74.21	70.03
Costs And Expenses	97.88% 210.77	106.52	83.97	78.02	73.48
Operating Income/Loss	6,415% -122.13	1.934	18.72	20.20	-2.053
Nonoperating Income/Loss	21.20% 3.579	4.542	3.691	3.806	3.456
Income/Loss From Continuing Operations Before Tax	1,931% -118.55	6.476	22.41	24.01	1.403
Income Tax Expense/Benefit	86.13% 0.242	1.745	1.518	1.933	-0.17
Income/Loss From Continuing Operations After Tax	2,611% -118.79	4.731	20.89	22.07	1.573
Net Income/Loss	2,611% -118.79	4.731	20.89	22.07	1.573
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	61,553% 67.85	0.1101	67.41	67.23	66.72
Diluted Average Shares	44,648% 67.85	-0.1523	69.75	70.13	70.86
Basic Earnings Per Share	2,600% -1.75	0.07	0.31	0.33	0.02
Diluted Earnings Per Share	2,600% -1.75	0.07	0.30	0.31	0.02
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-